Citigroup has recently resumed PACS Group Inc (PACS) stock to Buy rating, as announced on September 11, 2024, according to Finviz. Earlier, on June 28, 2024, Macquarie had initiated the stock to Outperform, setting a price target of $35. Truist also initiated Buy rating with a price target of $32. Additionally, Stephens initiated Overweight rating on May 6, 2024, with a target price of $31. RBC Capital Mkts analysts, in their report published on May 6, 2024, also initiated Outperform rating and set a price target of $30 for PACS Group Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
PACS Group Inc (PACS) Stock Trading Recap
On Tuesday, PACS Group Inc (PACS) stock saw a decline, ending the day at $38.88 which represents a decrease of $-1.09 or -2.73% from the prior close of $39.97. The stock opened at $39.96 and touched a low of $38.34 during the day, reaching a high of $39.97. The volume of shares traded was 1.33 million exceeding the average volume of 0.61 million.
PACS Stock Performance and Moving Averages
In recent trading, PACS Group Inc (PACS) stock price has shown some volatility, fluctuating -3.88% over the last five trades and -1.99% over the past 30 trades. This represents a notable shift from earlier in the year. The stock has gained 30.73% in the previous three months. Currently, PACS is trading at -1.84%, 2.71%, and 20.98% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, PACS, a Healthcare sector stock, is trading -7.98% below its 52-week high but remains 71.96% above its 52-week low. The Average True Range (ATR) (14 days) of 1.38 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
PACS Group Inc’s Profitability and Valuation Ratios
In terms of valuation, PACS Group Inc’s market capitalization stands at $6.03 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. The forward P/E ratio, which uses projected earnings for the next financial year, is 20.27. Additionally, the Price-to-Book Ratio is 10.36, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 76.91% of PACS Group Inc (PACS)’s shares, while financial institutions hold 19.41%.
Notable insider trades include Hancock Mark, Co-Founder & Exec. Vice Chair. at PACS Group Inc (PACS), who sold 8128352 shares on Sep 09 ’24, at $36.25 each, totaling $294.65 million. On Sep 09 ’24, Murray Jason Hulse, Co-Founder, CEO & Chairman, sold 8128352 shares for $36.25 each, amounting to $294.65 million. Additionally, on Apr 15 ’24, Murray Jason Hulse sold 1607142 shares at $21 each, generating $33.75 million.
